Prosoft Clinical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Prosoft Clinical is a long-established, privately-held CRO based in San Diego, California, serving the pharmaceutical, biotechnology, and medical device industries. The company differentiates itself through a full-service, integrated model that combines deep therapeutic expertise with proprietary technology platforms for data capture and management, aiming for efficiency and cost-effectiveness. Its team consists of seasoned professionals with an average of 20-30 years of experience from both sponsor and CRO environments, providing consultative support across all phases of product development, including ANDA, NDA, 510(k), and PMA submissions. Prosoft operates as a revenue-generating services business, supporting clients in navigating the complex clinical and regulatory pathway to market.

Digital Health

Technology Platform

Proprietary, integrated internal technology suite including an Electronic Data Capture (EDC) system and an IP management / Interactive Web Response (IWR) system, designed for rapid study build and data analysis without reliance on external vendors.

Opportunities

The growing trend of outsourcing in pharma and biotech R&D, coupled with the complexity of hybrid regulatory pathways like 505(b)(2) and 510(k), presents a sustained market need.

The company's proprietary, integrated technology platform positions it to offer efficient, cost-effective solutions in an industry increasingly focused on digital trial execution.

Risk Factors

Revenue is project-dependent and susceptible to client concentration and cyclical downturns in biotech funding.

The company faces intense competition from large global CROs and niche specialists, and must continuously invest in its technology platform and retain its experienced talent pool to maintain its competitive edge.

Competitive Landscape

Prosoft competes in the fragmented CRO market against large, full-service global players (e.g., IQVIA, ICON, Labcorp) and smaller niche CROs. Its differentiation is based on deep regulatory expertise in specific pathways (ANDA, 505(b)(2), 510(k)), a consultative approach from veteran staff, and an integrated, proprietary technology stack designed to reduce vendor reliance and increase efficiency for sponsors.

More companies in Digital Health & Biotech SaaS →More companies in United States →